The clinical trial supply chain is a complex and sensitive process that requires close monitoring to ensure patient safety. End-to-end condition monitoring is a powerful solution to improve the supply chain’s transparency and control.
In this webinar, the featured speakers discuss the benefits of implementing a temperature condition monitoring platform that seamlessly integrates with interactive response technology (IRT) systems for full end-to-end monitoring. Based on an actual use case, the speakers will share the learning points of implementing end-to-end monitoring and concrete outcomes in terms of improvements on process efficiency, monetary savings and patient safety.
This webinar will provide an outlook of implementing end-to-end temperature monitoring using modular real-time monitoring technology. This will bring an even higher level of control, with real-time oversight, even quicker decisive decision-making and quicker corrections in a more cost-effective manner. It will also allow for more sustainable processes and a significant reduction of the environmental impact of the clinical trial supply chain.
Don’t miss this webinar on end-to-end condition monitoring for the clinical trial supply chain and how its adoption can improve patient safety.
Register today.
Speakers
Silke Leiser, Director Clinical Trial Supply, EMD Serono
Silke Leiser works as the Director of Clinical Trial Supply supporting the healthcare business of Merck KGaA, Darmstadt, Germany which operates in the US and Canada as EMD Serono. Silke is a biologist by profession and studied at the University of Mainz and Würzburg. She joined Merck CTS in 2005 and gained her experience in the global clinical trial business. Silke is currently focusing on innovations & technologies for clinical trial supplies. This includes the fields of interactive response technologies, material demand planning, optimizing supply activities, as well as patient-centric approaches on packaging design, adherence monitoring and digitalization of CTS processes like IMP temperature tracking.
Message Presenter
Harald van Weeren, Segment Manager Clinical Trials, Head of Segment Management, Berlinger & Co. AG
Harald van Weeren is the Segment Manager clinical trials, and Head of Segment Management at Berlinger & Co. AG. Harald holds a PhD in physics from the University of Twente, The Netherlands. He has over 15 years of experience in product management and market segment management in various high-tech industries. Harald joined Berlinger in 2020 where is responsible for keeping track of market trends in Clinical Trials for Berlinger to offer the best value in this market segment. In addition, he heads the segment management department at Berlinger.
Message PresenterWho Should Attend?
- Clinical trial managers and clinical research organizations who are seeking to improve the efficiency of their clinical trials
- Clinical trial supply managers who are seeking to get rapid and complete oversight on the condition of the IMPs
- Quality managers who are seeking ways to further safeguard quality standards
- IRT suppliers who are seeking to find new USPs in their product portfolio and want to increase customer satisfaction
- CDMOs and logistics providers who are seeking to further increase customer satisfaction
What You Will Learn
Attendees will discover:
- How end-to-end condition monitoring can improve patient safety and increase process efficiency in the clinical trial supply chain
- How to turn an average of 25-day manual temperature-monitoring data evaluation into instant decision-making
- How the implementation of an open condition monitoring platform, together with the use of modular real-time monitoring technology, can bring significant benefits to the clinical trial industry
- How site burden is reduced using real-time monitoring
Xtalks Partner
Berlinger
The Swiss company Berlinger & Co. AG develops, produces, and distributes innovative condition monitoring solutions for pharmaceutical and medical technology products with the aim of further increasing efficiency and improving patient safety. Berlinger has been a family business since it was founded in 1865, which allows us to think far beyond quarterly results.
Berlinger is fully committed to long-term customer success, as they think in generations. Innovation and quality are key for Berlinger to deliver customers success. Berlinger invests a considerable amount in R&D every year to stay innovative as they did the last 155 years, are truly international, and proudly partner with leading pharmaceutical companies and major healthcare organizations in over 175 countries for over 30 years.
Related Webinars
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account